The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
about
RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer controlThe therapeutic value of targeting inflammation in gastrointestinal cancersPhosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human diseaseApigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expressionShotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics.Similarity in viral and host promoters couples viral reactivation with host cell migrationTNF-α promotes gallbladder cancer cell growth and invasion through autocrine mechanismsGalectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.Gene expression pathways of high grade localized prostate cancer.NF-κB-modulated miR-130a targets TNF-α in cervical cancer cellsChemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targetingEmodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinomaThe Analysis of the Relationship between Multiple Myeloma Cells and Their MicroenvironmentAcetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression.Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α.Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor.Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer.Quantitative analysis of the TNF-α-induced phosphoproteome reveals AEG-1/MTDH/LYRIC as an IKKβ substrate.Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast CancerThe chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium.Role of chemokines in tumor growth.The A2b adenosine receptor protects against vascular injury.Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.The tumor microenvironment: key to early detection.The peritoneal tumour microenvironment of high-grade serous ovarian cancer.Endometriosis-associated ovarian cancer: a review of pathogenesisCharacteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells.Cytokine patterns in brain tumour progression.Tumor necrosis factor and cancer, buddies or foes?Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cellsThe inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells.Fatigue and sleep during cancer and chemotherapy: translational rodent models
P2860
Q24608385-E99C5120-0958-4C88-9CDD-639DD539736BQ26860058-BE413A7F-37FE-48F0-BF9F-32FB0123B296Q27024203-154CF89C-EB6B-45B7-A273-80D5CDDCB8E2Q28386527-3B06ECC2-5920-435C-BDEF-A22AA03E170DQ28390782-745EBAA8-1AEA-4DB3-8B67-1F655431D4BFQ33262142-1C9EA06C-CE00-41A3-B6B2-FE9CF75C8FC6Q33640033-00343152-09C4-44F2-B9E7-935928DE07F3Q33747708-510AFDF1-5A48-44A0-B570-AA353F27F195Q33814898-83D9E04C-A0E5-47B2-AA12-CB1A0E2201F3Q33832517-147232C7-857D-4966-930A-47AD18D0334FQ33854606-9D18365F-5BCC-48AE-BA7D-F6013EF280E8Q34010429-0E98B16A-53D4-45BC-909F-57A4AD336666Q34614290-DC6EF7A8-10F9-4412-A5F8-88278E1158C0Q34791709-E61EBAB9-0D0E-476C-8FCF-418824C58036Q34861014-7769C620-BFCE-405A-9B83-191556E5F000Q34936465-3CB8198E-59DF-45B1-AA89-7338BA6102DDQ35125413-FE93E86D-1D2C-4A76-9CF6-5A5250F417F9Q35167546-29920F61-0A77-4553-8429-98AA9B763F77Q35218676-3816E52A-A5F5-409C-93AD-591E56540156Q35264283-A41BC06C-90BE-4528-9694-5AC00D5E6387Q35407312-74D93F60-425E-4ED7-8542-A09A9DFA16E3Q35669726-18677698-58CA-4775-A715-8BA4466B0621Q35844698-45B011FF-FF3F-4D9B-B508-E92B2E02F52FQ35858991-FAC17A59-851A-4FBC-B300-045D9D87E4C0Q35879531-A2FC66AE-D944-4477-8EC4-721B5C601A67Q36043441-A3CC4278-C3DE-4FF4-93A2-DE62FD2847F1Q36120825-513561B0-2B8E-4F6A-9DEC-405CC5731A3EQ36393058-71AAC11F-3B26-4704-827C-0BCD4842C816Q36446437-2E34397B-41FF-4332-8EA9-804A2CE7F2D2Q36568998-58A3F837-1327-4B7D-B24B-3713F3B8BFF8Q36627750-C16B2DEF-3E18-4B35-8F88-AAAF3883CB3CQ36719074-F3300673-C59D-4309-AB12-A673F4BDD8FDQ36790454-5F8442C5-86DE-48D9-BF3A-6E5A7CD300BCQ36960019-4FAB77B5-ECA4-412B-B9C6-8FBFEED39CFEQ36999339-4C7F4DBD-AEEC-49FB-9184-1652B9817E5DQ37073092-BC4C33F9-04E5-4B1C-ACA2-40EE57C562A7Q37085845-9284B3CD-6537-434D-938F-A7F80E005BEDQ37186494-766372A8-1176-4E55-B370-87AA7F058804Q37200457-5D7358B5-2585-47AF-92FA-D8C55C4E8CE2Q37203219-716E4741-9034-45CE-9FD3-6F13E8D46A20
P2860
The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The inflammatory cytokine tumo ...... ssion on ovarian cancer cells.
@en
type
label
The inflammatory cytokine tumo ...... ssion on ovarian cancer cells.
@en
prefLabel
The inflammatory cytokine tumo ...... ssion on ovarian cancer cells.
@en
P2093
P1433
P1476
The inflammatory cytokine tumo ...... ssion on ovarian cancer cells.
@en
P2093
Hagen Kulbe
Julia L Wilson
Piotr W Szlosarek
Thorsten Hagemann
P304
10355-10362
P356
10.1158/0008-5472.CAN-05-0957
P407
P577
2005-11-01T00:00:00Z